Tuesday, 28 April 2015

Chronic obstructive pulmonary disease increases the risk of sudden cardiac death

People suffering from the common lung disease, chronic obstructive pulmonary disease (COPD), have an increased risk of sudden cardiac death (SCD), according to new research published online today (Wednesday) in the European Heart Journal.

When compared with people of the same and sex who do not have the disease, those with COPD have a 34% increased risk of SCD overall, but their risk almost doubles more than five years after first being diagnosed with COPD. In COPD patients who have frequent exacerbations (sudden worsening of their symptoms, such as shortness of breath and cough), the risk of SCD increases more than three-fold after five years.

The Rotterdam study of nearly 15,000 people aged 45 and older is the first to show that COPD is associated with an increased risk of SCD in the general population and that this remains the case even when taking into account the fact that COPD is known to increase the risk of death from any cause.

The researchers say that their findings should help doctors to assess their patients' risk of SCD more accurately, as well as suggesting directions for further research into how to target preventive action more effectively for patients with COPD. Preventive treatments could include beta-blockers, implantable cardioverter defibrillators (ICD) to regulate heartbeat, or the withdrawal of drugs that prolong the interval between the two waves (Q and T) of the heart's electrical cycle, such as adrenaline, various cold remedies, some antibiotics and anti-depressants.

"Sudden cardiac death (SCD) is a major health problem; however, risk stratification remains difficult and probably not all risk indicators have been identified," they write in their EHJ paper. "Chronic (COPD) has been associated with an of and with SCD in specific high-risk patient populations. This study shows that COPD is a risk indicator for SCD in the general population and that the risk increases with COPD severity. This provides directions for further measures to prevent SCD."

Dr Lies Lahousse, who led the research and is a post-doctoral researcher in the Department of Respiratory Medicine at Ghent University Hospital, Belgium, said: "We are carrying out further research to explore the mechanisms that could explain the high risk of SCD in patients with COPD. We are also looking at the links between the causes of arrhythmias - irregular heart beats - and SCD and COPD."

A co-author of the paper, Dr Marieke Niemeijer, a medical doctor and PhD student in the Department of Epidemiology at Erasmus Medical Centre, Rotterdam, The Netherlands, said: "The most important way to prevent COPD and SCD is not to smoke and to have a healthy lifestyle. If a person does develop COPD, then this is even more important, as smoking, an unhealthy and a sedentary lifestyle have been proven to increase the risk of SCD. Therefore, smoking cessation is not only important for the course of COPD but also for the development of heart problems and, subsequently, the occurrence of SCD."

SCD is a sudden, unexpected death caused by the heart ceasing to work. It is responsible for approximately half of all the four to five million deaths worldwide. It has a number of causes, which makes it difficult to assess adequately a person's risk and to plan prevention strategies. COPD is the world's third leading cause of death, with smoking as the most significant cause of the disease. It is also more likely to develop as people age. Chronic inflammation in the airways and lungs leads to progressive limitation of airflow, and patients have a two- to three-fold higher risk of developing diseases of the heart and blood vessels.

The ongoing Rotterdam study, which started in 1990 in The Netherlands, has been following 14,926 people living in the community, aged 45 and older, for up to 24 years. The participants have regular medical examinations and are continuously monitored so that deaths and medical conditions and diseases are recorded.

The researchers in The Netherlands and Belgium included 13,471 people from the study in their analysis; of these, 1615 were diagnosed with COPD. Of the 5197 (39%) study participants who died, 551 died due to SCD during the follow-up period and of these 82 (15%) had COPD and 469 (85%) did not. People with COPD who died due to SCD were more likely to die during the night.

More information: "Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study", by Lies Lahousse et al. European Heart Journal. DOI: 10.1093/eurheartj/ehv121

Medical Xpress on facebook

Related Stories

Oxygen therapy in COPD patients is associated with burn injury

date Mar 30, 2015

Researchers from the University of Texas Medical Branch at Galveston have found that patients with chronic obstructive pulmonary disease receiving home oxygen have a higher risk of burn injury. This study was published on ...

COPD takes big toll on employment, mobility in US

date Mar 27, 2015

(HealthDay)—The respiratory illness known as COPD takes a toll on mobility and employment, with a new report finding that nearly one-quarter of Americans with the condition are unable to work.

COPD patients at significantly higher risk of heart failure

date May 18, 2014

As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to ...

High-risk carotid artery plaque formation is increased in older COPD patients

date Oct 26, 2012

Older patients with chronic obstructive pulmonary disease (COPD) are at increased risk for carotid artery plaque formation and for the presence of vulnerable plaques with a lipid core, according to a new study from researchers ...

Study finds adverse respiratory outcomes for older people with COPD taking benzodiazepines

date Apr 17, 2014

A group of drugs commonly prescribed for insomnia, anxiety and breathing issues "significantly increase the risk" that older people with chronic obstructive pulmonary disease, or COPD, need to visit a doctor or Emergency ...

Recommended for you

Study allays concerns that cardiothoracic physicians-in-training provide suboptimal care

date 3 hours ago

A conundrum in medical education is how to train residents in complex and technically difficult procedures without reducing the quality of patient care. In an analysis of prospective data from a study of coronary artery bypass ...

First-of-its-kind clinical guide explains uses and limitations of public blood pressure kiosks

date 5 hours ago

High blood pressure affects one in three adults in the United States, and blood pressure measurement is the first step toward accurate diagnosis and management of the disease. The Food and Drug Administration acknowledges ...

Polygamy increases risk of heart disease by more than four-fold

date 5 hours ago

APSC 2015 is being held in Abu Dhabi from 29 April to 2 May in conjunction with the XX World Congress of Echocardiography and Allied Techniques 2015 and the 6th Annual Emirates Cardiac Society Congress 2015. ...

Study reveals first six months best for stimulating heart growth

date 6 hours ago

In a recent issue of Science Translational Medicine, Brian Polizzotti, PhD, Bernhard Kuhn, MD, Sangita Choudhury, PhD, and colleagues affiliated with the Boston Children's Hospital's Translational Resear ...

Age at surgery and valve type in PVR key determinants of re-intervention in congenital heart disease

date 7 hours ago

Over the last 15 years, survival of children with congenital heart disease (CHD) has greatly improved, so that currently there are more adults than children living with CHD. Consequently, people with CHD of all ages are undergoing ...

New class of cholesterol drug proves safe and effective for patients with dyslipidemia

date Apr 27, 2015

Treatment with PCSK9 antibodies reduces mortality and produces profound reductions in LDL-cholesterol and lipoprotein in patients with dyslipidemia. The results of this systematic review and meta-analysis are being published ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.

People suffering from the common lung disease, chronic obstructive pulmonary disease (COPD), have an increased risk of sudden cardiac death (SCD), according to new research published online today (Wednesday) in the European Heart Journal.

When compared with people of the same and sex who do not have the disease, those with COPD have a 34% increased risk of SCD overall, but their risk almost doubles more than five years after first being diagnosed with COPD. In COPD patients who have frequent exacerbations (sudden worsening of their symptoms, such as shortness of breath and cough), the risk of SCD increases more than three-fold after five years.

The Rotterdam study of nearly 15,000 people aged 45 and older is the first to show that COPD is associated with an increased risk of SCD in the general population and that this remains the case even when taking into account the fact that COPD is known to increase the risk of death from any cause.

The researchers say that their findings should help doctors to assess their patients' risk of SCD more accurately, as well as suggesting directions for further research into how to target preventive action more effectively for patients with COPD. Preventive treatments could include beta-blockers, implantable cardioverter defibrillators (ICD) to regulate heartbeat, or the withdrawal of drugs that prolong the interval between the two waves (Q and T) of the heart's electrical cycle, such as adrenaline, various cold remedies, some antibiotics and anti-depressants.

"Sudden cardiac death (SCD) is a major health problem; however, risk stratification remains difficult and probably not all risk indicators have been identified," they write in their EHJ paper. "Chronic (COPD) has been associated with an of and with SCD in specific high-risk patient populations. This study shows that COPD is a risk indicator for SCD in the general population and that the risk increases with COPD severity. This provides directions for further measures to prevent SCD."

Dr Lies Lahousse, who led the research and is a post-doctoral researcher in the Department of Respiratory Medicine at Ghent University Hospital, Belgium, said: "We are carrying out further research to explore the mechanisms that could explain the high risk of SCD in patients with COPD. We are also looking at the links between the causes of arrhythmias - irregular heart beats - and SCD and COPD."

A co-author of the paper, Dr Marieke Niemeijer, a medical doctor and PhD student in the Department of Epidemiology at Erasmus Medical Centre, Rotterdam, The Netherlands, said: "The most important way to prevent COPD and SCD is not to smoke and to have a healthy lifestyle. If a person does develop COPD, then this is even more important, as smoking, an unhealthy and a sedentary lifestyle have been proven to increase the risk of SCD. Therefore, smoking cessation is not only important for the course of COPD but also for the development of heart problems and, subsequently, the occurrence of SCD."

SCD is a sudden, unexpected death caused by the heart ceasing to work. It is responsible for approximately half of all the four to five million deaths worldwide. It has a number of causes, which makes it difficult to assess adequately a person's risk and to plan prevention strategies. COPD is the world's third leading cause of death, with smoking as the most significant cause of the disease. It is also more likely to develop as people age. Chronic inflammation in the airways and lungs leads to progressive limitation of airflow, and patients have a two- to three-fold higher risk of developing diseases of the heart and blood vessels.

The ongoing Rotterdam study, which started in 1990 in The Netherlands, has been following 14,926 people living in the community, aged 45 and older, for up to 24 years. The participants have regular medical examinations and are continuously monitored so that deaths and medical conditions and diseases are recorded.

The researchers in The Netherlands and Belgium included 13,471 people from the study in their analysis; of these, 1615 were diagnosed with COPD. Of the 5197 (39%) study participants who died, 551 died due to SCD during the follow-up period and of these 82 (15%) had COPD and 469 (85%) did not. People with COPD who died due to SCD were more likely to die during the night.

More information: "Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study", by Lies Lahousse et al. European Heart Journal. DOI: 10.1093/eurheartj/ehv121

Medical Xpress on facebook

Related Stories

Oxygen therapy in COPD patients is associated with burn injury

date Mar 30, 2015

Researchers from the University of Texas Medical Branch at Galveston have found that patients with chronic obstructive pulmonary disease receiving home oxygen have a higher risk of burn injury. This study was published on ...

COPD takes big toll on employment, mobility in US

date Mar 27, 2015

(HealthDay)—The respiratory illness known as COPD takes a toll on mobility and employment, with a new report finding that nearly one-quarter of Americans with the condition are unable to work.

COPD patients at significantly higher risk of heart failure

date May 18, 2014

As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to ...

High-risk carotid artery plaque formation is increased in older COPD patients

date Oct 26, 2012

Older patients with chronic obstructive pulmonary disease (COPD) are at increased risk for carotid artery plaque formation and for the presence of vulnerable plaques with a lipid core, according to a new study from researchers ...

Study finds adverse respiratory outcomes for older people with COPD taking benzodiazepines

date Apr 17, 2014

A group of drugs commonly prescribed for insomnia, anxiety and breathing issues "significantly increase the risk" that older people with chronic obstructive pulmonary disease, or COPD, need to visit a doctor or Emergency ...

Recommended for you

Study allays concerns that cardiothoracic physicians-in-training provide suboptimal care

date 3 hours ago

A conundrum in medical education is how to train residents in complex and technically difficult procedures without reducing the quality of patient care. In an analysis of prospective data from a study of coronary artery bypass ...

First-of-its-kind clinical guide explains uses and limitations of public blood pressure kiosks

date 5 hours ago

High blood pressure affects one in three adults in the United States, and blood pressure measurement is the first step toward accurate diagnosis and management of the disease. The Food and Drug Administration acknowledges ...

Polygamy increases risk of heart disease by more than four-fold

date 5 hours ago

APSC 2015 is being held in Abu Dhabi from 29 April to 2 May in conjunction with the XX World Congress of Echocardiography and Allied Techniques 2015 and the 6th Annual Emirates Cardiac Society Congress 2015. ...

Study reveals first six months best for stimulating heart growth

date 6 hours ago

In a recent issue of Science Translational Medicine, Brian Polizzotti, PhD, Bernhard Kuhn, MD, Sangita Choudhury, PhD, and colleagues affiliated with the Boston Children's Hospital's Translational Resear ...

Age at surgery and valve type in PVR key determinants of re-intervention in congenital heart disease

date 7 hours ago

Over the last 15 years, survival of children with congenital heart disease (CHD) has greatly improved, so that currently there are more adults than children living with CHD. Consequently, people with CHD of all ages are undergoing ...

New class of cholesterol drug proves safe and effective for patients with dyslipidemia

date Apr 27, 2015

Treatment with PCSK9 antibodies reduces mortality and produces profound reductions in LDL-cholesterol and lipoprotein in patients with dyslipidemia. The results of this systematic review and meta-analysis are being published ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here

to reset your password.

Sign in to get notified via email when new comments are made.



Categories:

0 comments:

Post a Comment